Literature DB >> 8761498

Primary coronary angioplasty in acute myocardial infarction.

E D Grech1, D R Ramsdale.   

Abstract

It is well established that recanalisation of the infarct-related artery is of great benefit in the early hours after acute myocardial infarction. This can be achieved by the use of thrombolytic agents and/or by percutaneous transluminal coronary angioplasty (PTCA). This article reviews data on the role of primary PTCA and summarises current opinion on its use.

Entities:  

Mesh：

Year:  1996        PMID： 8761498      PMCID： PMC2398472          DOI： 10.1136/pgmj.72.847.269

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  30 in total

1.  Results of primary angioplasty for acute myocardial infarction in patients with multivessel coronary artery disease.

Authors:  J K Kahn; B D Rutherford; D R McConahay; W L Johnson; L V Giorgi; T M Shimshak; R Ligon; G O Hartzler
Journal:  J Am Coll Cardiol       Date:  1990-11       Impact factor: 24.094

2.  Usefulness of angioplasty during acute myocardial infarction in patients with prior coronary artery bypass grafting.

Authors:  J K Kahn; B D Rutherford; D R McConahay; W Johnson; L V Giorgi; R Ligon; G O Hartzler
Journal:  Am J Cardiol       Date:  1990-03-15       Impact factor: 2.778

3.  Sequential intervention procedures after intracoronary thrombolysis; balloon dilatation, bypass surgery, and medical treatment.

Authors:  J Meyer; W Merx; R Dörr; R Erbel; R von Essen; H Lambertz; C Bethge; H J Schmitz; P Bardos; C Minale
Journal:  Int J Cardiol       Date:  1985-03       Impact factor: 4.164

4.  Emergency percutaneous transluminal coronary angioplasty for acute myocardial infarction in patients 70 years of age and older.

Authors:  T C Lee; L A Laramee; B D Rutherford; D R McConahay; W L Johnson; L V Giorgi; R W Ligon; G O Hartzler
Journal:  Am J Cardiol       Date:  1990-09-15       Impact factor: 2.778

5.  Early and late results of coronary angioplasty without antecedent thrombolytic therapy for acute myocardial infarction.

Authors:  J H O'Keefe; B D Rutherford; D R McConahay; R W Ligon; W L Johnson; L V Giorgi; J E Crockett; B D McCallister; R D Conn; G M Gura
Journal:  Am J Cardiol       Date:  1989-12-01       Impact factor: 2.778

6.  Sudden paradoxic clinical deterioration during angioplasty of the occluded right coronary artery in acute myocardial infarction.

Authors:  G M Gacioch; E J Topol
Journal:  J Am Coll Cardiol       Date:  1989-11-01       Impact factor: 24.094

7.  A prospective randomized clinical trial of intracoronary streptokinase versus coronary angioplasty for acute myocardial infarction.

Authors:  W O'Neill; G C Timmis; P D Bourdillon; P Lai; V Ganghadarhan; J Walton; R Ramos; N Laufer; S Gordon; M A Schork
Journal:  N Engl J Med       Date:  1986-03-27       Impact factor: 91.245

8.  Percutaneous transluminal coronary angioplasty with and without thrombolytic therapy for treatment of acute myocardial infarction.

Authors:  G O Hartzler; B D Rutherford; D R McConahay; W L Johnson; B D McCallister; G M Gura; R C Conn; J E Crockett
Journal:  Am Heart J       Date:  1983-11       Impact factor: 4.749

9.  Direct coronary angioplasty in acute myocardial infarction: outcome in patients with single vessel disease.

Authors:  G W Stone; B D Rutherford; D R McConahay; W L Johnson; L V Giorgi; R W Ligon; G O Hartzler
Journal:  J Am Coll Cardiol       Date:  1990-03-01       Impact factor: 24.094

10.  The spectrum of pathology associated with percutaneous transluminal coronary angioplasty during acute myocardial infarction.

Authors:  P G Colavita; R E Ideker; K A Reimer; D B Hackel; R S Stack
Journal:  J Am Coll Cardiol       Date:  1986-10       Impact factor: 24.094
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.